NDC 0944-5001

OBIZUR

Antihemophilic Factor (recombinant), Porcine Sequence

OBIZUR is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .

• Product ID: 0944-5001_1035bf89-ce7c-4986-b4f1-5b44c2ce0be0
• NDC: 0944-5001
• Product Type: Plasma Derivative
• Proprietary Name: OBIZUR
• Generic Name: Antihemophilic Factor (recombinant), Porcine Sequence
• Dosage Form: Kit
• Marketing Start Date: 2014-10-23
• Marketing Category: BLA / BLA
• Application Number: BLA125512
• Labeler Name: Baxalta US Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0944-5001-01

1 KIT in 1 CARTON (0944-5001-01) * 1 mL in 1 VIAL, GLASS (0944-5011-01) * 1 mL in 1 SYRINGE, GLASS (0944-0011-01)

• Marketing Start Date: 2014-10-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0944-5001-01 [00944500101]

OBIZUR KIT

• Marketing Category: BLA
• Application Number: BLA125512
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2014-10-23

NDC 0944-5001-10 [00944500110]

OBIZUR KIT

• Marketing Category: BLA
• Application Number: BLA125512
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2014-10-23

NDC 0944-5001-05 [00944500105]

OBIZUR KIT

• Marketing Category: BLA
• Application Number: BLA125512
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2014-10-23

Drug Details